AIIMS Delhi to conduct Phase 2, 3 clinical trials of Bharat Biotech's nasal vaccine soon: Sources

The All India Institute Of Medical Sciences (AIIMS) here will be starting Phase 2/3 trials of Hyderabad-based Covid-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon, sources informed on Wednesday. Amid ongoing research in many countries to develop nasal spray to help prevent Covid-19, Bharat Biotech's intranasal vaccine received regulatory approval for second Phase trials in August.

source https://timesofindia.indiatimes.com/india/aiims-delhi-to-conduct-phase-2-3-clinical-trials-of-bharat-biotechs-nasal-vaccine-soon-sources/articleshow/86047124.cms